Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Clinical images

Purple urine bag syndrome

Che-Kim Tan, Ya-Ping Wu, Hsing-Ying Wu and Chih-Cheng Lai
CMAJ August 26, 2008 179 (5) 491; DOI: https://doi.org/10.1503/cmaj.071604
Che-Kim Tan MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ya-Ping Wu RT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hsing-Ying Wu RT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chih-Cheng Lai MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading
  • © 2008 Canadian Medical Association

A 58-year-old man with an indwelling urinary catheter began producing urine with a deep purple colour (Figure 1). The urine was alkaline (pH 7.8), and Proteus mirabilis urinary tract infection was diagnosed. This so-called purple urine bag syndrome resolved after treatment with ceftazidime. The phenomenon occurs over a 2-year period in about 8% of patients with indwelling urinary catheters.1 The syndrome is often associated with a urinary tract infection caused by Providencia bacteria, Escherichia coli, P. mirabilis or Klebsiella pneumoniae. These bacteria produce an enzyme (indoxyl phosphatase/sulfatase) that converts the excreted indoxyl sulfate in the urine into red-and blue-coloured compounds (indirubin and indigo), which mix to form the purple colour.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1: Purple-coloured urine of a 58-year-old man with an indwelling catheter.

Tryptophan normally exists in the intestine and is degraded into indoxyl sulfate. This in turn is absorbed and excreted in the urine. Constipation, which prolongs tryptophan transit time in the intestine, results in increased indoxyl sulfate levels in urine and is a risk factor for purple urine bag syndrome. Other risk factors include alkaline urine (which predisposes to the growth of contributory microbes) and the use of catheters made of polyvinyl chloride plastic.1 Women are at greater risk than men for this condition.

Urine colour may change for many reasons. Purple urine can be associated with intestinal intussusception.2 A green colour can occur with Pseudomonas urinary tract infections or if a patient has taken methylene blue, amitriptyline, indomethacin, doxorubicin or propofol. A deep orange colour can be associated with treatment with rifampin or warfarin.

Footnotes

  • Clinical images are chosen because they are particularly intriguing, classic or dramatic. Submissions of clear, appropriately labelled high-resolution images must be accompanied by a figure caption and the patient's written consent for publication. A brief explanation (300 words maximum) of the educational significance of the images, with minimal references, is required.

REFERENCES

  1. 1.↵
    Su FH, Chung SY, Chen MH, et al. Case analysis of purple urine-bag syndrome at a long-term care service in a community hospital. Chang Gung Med J 2005;28:636-42.
    OpenUrlPubMed
  2. 2.↵
    Pillai RN, Clavijo J, Narayanan M, et al. An association of purple urine bag syndrome with intussusception. Urology 2007;70:812.e1-2.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 179 (5)
CMAJ
Vol. 179, Issue 5
26 Aug 2008
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Purple urine bag syndrome
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Purple urine bag syndrome
Che-Kim Tan, Ya-Ping Wu, Hsing-Ying Wu, Chih-Cheng Lai
CMAJ Aug 2008, 179 (5) 491; DOI: 10.1503/cmaj.071604

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Purple urine bag syndrome
Che-Kim Tan, Ya-Ping Wu, Hsing-Ying Wu, Chih-Cheng Lai
CMAJ Aug 2008, 179 (5) 491; DOI: 10.1503/cmaj.071604
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights
  • Dans ce numéro
  • PubMed
  • Google Scholar

Cited By...

  • The purple urine bag syndrome
  • Google Scholar

More in this TOC Section

  • Subungual malignant melanoma
  • Diffuse panbronchiolitis
  • Tension gastrothorax: a life-threatening cause of acute abdominal pain
Show more Clinical Images

Similar Articles

Collections

  • Topics
    • Urology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire